This HTML5 document contains 66 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q91797052
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована 1 квітня 2019 artículu científicu espublizáu n'abril de 2019 im April 2019 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 April 2019
p:P577
wds:Q91797052-ED2F7B06-76EC-45BC-B355-30344E1FEA99
wdt:P577
2019-04-01T00:00:00Z
p:P2093
wds:Q91797052-25CB6DEB-82A8-4357-9493-0553F5408A59 wds:Q91797052-3B0C1C9C-B3BB-4DEF-8BB3-01BBC6DD8185
wdt:P2093
Dragos Vinereanu Denis Xavier
rdfs:label
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
skos:prefLabel
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
schema:name
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
p:P50
wds:Q91797052-84E06BE3-FF84-4E5B-9414-25736A00BB34 wds:Q91797052-9C0CA4DA-2C5D-4508-BB6C-11DB8B28C0C9 wds:Q91797052-A16FCA0E-9B13-46EA-9F3B-23E705A28A59 wds:Q91797052-097617B2-6C1D-44A1-A1C3-215D788AEC63 wds:Q91797052-0E90033F-049A-48F9-A7A3-503432EF252B wds:Q91797052-0CE8317D-F2D6-4632-A05E-E48BFD73278F wds:Q91797052-0345516A-A4B9-4211-A5B5-26986140486B wds:Q91797052-D716735C-8B11-4500-9A4D-DBD53C1CF1E1 wds:Q91797052-C0E3EB22-26AD-4EF0-B006-E6CC42C4E407 wds:Q91797052-E0316F1F-18CC-4956-847B-494F037AC5DE wds:Q91797052-DB00DF49-9779-4EBD-92BF-10DD6F721151 wds:Q91797052-E8CF8CCA-945F-4C0F-BDA2-341EE1090D4C wds:Q91797052-F74CD6A1-D72D-4255-9A66-869D2A0DC464
wdt:P50
wd:Q110902934 wd:Q100694590 wd:Q92473614 wd:Q91797048 wd:Q114304484 wd:Q62050240 wd:Q43198009 wd:Q6230815 wd:Q110877755 wd:Q120703226 wd:Q73022836 wd:Q90906040 wd:Q114775434
p:P1476
wds:Q91797052-8B4CA7DF-068F-4769-944D-1EFD8545C058
wdt:P1476
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial
p:P304
wds:Q91797052-0C077E26-71E1-406D-AAC0-5E2D3045CE6F
wdt:P304
345-352
p:P31
wds:Q91797052-260E9A33-1B50-48F1-93AA-DC6D3200A019
wdt:P31
wd:Q13442814
p:P921
wds:Q91797052-9E7C70CF-C472-423C-BE36-9111A0DB3C9F wds:Q91797052-B202269F-CCE8-4FAA-8418-18D0B3FDCE1C
wdt:P921
wd:Q407431 wd:Q414462
p:P698
wds:Q91797052-022381A1-9855-46AD-9BAB-B9802F0FD14E
wdtn:P698
n12:30790160
wdt:P698
30790160
p:P1433
wds:Q91797052-2B3ED7CC-A112-48FA-8C95-798DB20A646E
wdt:P1433
wd:Q15766541
p:P433
wds:Q91797052-2B99DB55-A192-46B9-ABA8-9EB794BD0360
p:P478
wds:Q91797052-F60C9C41-1818-40CB-9E0D-965116E35573
wdt:P433
3
wdt:P478
47
p:P356
wds:Q91797052-20587318-998D-42CA-8A71-1589F2AB425B
wdtn:P356
n8:S11239-019-01823-Y
wdt:P356
10.1007/S11239-019-01823-Y